Biphenylalkoxyamine Derivatives-Histamine H
Acetylcholinesterase
/ chemistry
Alzheimer Disease
/ drug therapy
Amines
/ chemistry
Animals
Butyrylcholinesterase
/ chemistry
Cell Line
Cholinesterase Inhibitors
/ chemical synthesis
Humans
Ligands
Male
Mice
Models, Animal
Molecular Docking Simulation
Molecular Structure
Monoamine Oxidase
/ chemistry
Receptors, Histamine H3
/ chemistry
Structure-Activity Relationship
Alzheimer’s disease
butyrylcholinesterase inhibitors
histamine H3 receptor ligands
monoamine oxidase inhibitors
multi-target ligands
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
11 Jun 2021
11 Jun 2021
Historique:
received:
19
05
2021
revised:
05
06
2021
accepted:
07
06
2021
entrez:
2
7
2021
pubmed:
3
7
2021
medline:
29
7
2021
Statut:
epublish
Résumé
Neurodegenerative diseases, e.g., Alzheimer's disease (AD), are a key health problem in the aging population. The lack of effective therapy and diagnostics does not help to improve this situation. It is thought that ligands influencing multiple but interconnected targets can contribute to a desired pharmacological effect in these complex illnesses. Histamine H
Identifiants
pubmed: 34208297
pii: molecules26123580
doi: 10.3390/molecules26123580
pmc: PMC8231170
pii:
doi:
Substances chimiques
Amines
0
Cholinesterase Inhibitors
0
Ligands
0
Receptors, Histamine H3
0
Monoamine Oxidase
EC 1.4.3.4
Acetylcholinesterase
EC 3.1.1.7
Butyrylcholinesterase
EC 3.1.1.8
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : the National Science Centre, Poland
ID : UMO-2016/23/B/NZ7/02327
Références
Expert Opin Ther Pat. 2018 Mar;28(3):175-196
pubmed: 29334795
Int J Mol Sci. 2013 Mar 11;14(3):5608-32
pubmed: 23478436
Eur J Med Chem. 2017 May 26;132:294-309
pubmed: 28371641
Anal Biochem. 1997 Nov 15;253(2):169-74
pubmed: 9367499
Drug Discov Today. 2019 Feb;24(2):629-635
pubmed: 30503804
Alzheimers Res Ther. 2017 Aug 1;9(1):57
pubmed: 28764767
Biochem Pharmacol. 1961 Jul;7:88-95
pubmed: 13726518
Brain Res. 2017 Sep 15;1671:102-110
pubmed: 28729192
Bioorg Med Chem. 2018 Aug 7;26(14):4034-4046
pubmed: 29960729
Front Neurosci. 2016 May 30;10:201
pubmed: 27303254
J Med Chem. 2019 Jan 24;62(2):420-444
pubmed: 30035545
J Med Chem. 2019 Oct 24;62(20):9116-9140
pubmed: 31609115
J Enzyme Inhib Med Chem. 2021 Dec;36(1):491-496
pubmed: 33478277
Neuroscience. 2015 Jul 9;298:424-35
pubmed: 25931333
Eur J Med Chem. 2020 Dec 1;207:112743
pubmed: 32882609
Sci Rep. 2017 Mar 03;7:42717
pubmed: 28256516
Structure. 1999 Mar 15;7(3):297-307
pubmed: 10368299
Eur J Med Chem. 2020 Jul 1;197:112282
pubmed: 32380361
J Alzheimers Dis. 2017;58(2):491-505
pubmed: 28453492
Biochem Pharmacol. 1973 Dec 1;22(23):3099-108
pubmed: 4202581
Nature. 1983 Apr 28;302(5911):832-7
pubmed: 6188956
Bioorg Med Chem. 2017 Oct 15;25(20):5341-5354
pubmed: 28797771
Angew Chem Int Ed Engl. 2017 Oct 2;56(41):12765-12769
pubmed: 28861918
Pharmacol Ther. 2019 Aug;200:69-84
pubmed: 31028835
Mol Pharmacol. 2016 Nov;90(5):649-673
pubmed: 27563055
Eur J Med Chem. 2020 Jan 1;185:111785
pubmed: 31669851
J Med Chem. 2020 Sep 10;63(17):10030-10044
pubmed: 32787113
Bioorg Med Chem Lett. 2018 Dec 15;28(23-24):3596-3600
pubmed: 30404719
Nucleic Acids Res. 2018 Jul 2;46(W1):W257-W263
pubmed: 29718510
Pharmacol Rep. 2015 Dec;67(6):1155-62
pubmed: 26481535